阿尔德脱酶2通过抑制CYP4A的表达减轻损伤
Hao Chen1, Qianchao Hu1, Zhongshan Lu1
1Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Engineering Research Center of Natural Polymer-based Medical Materials in Hubei Province, Wuhan 430071, China.
概括
阿尔德脱酶2 (ALDH2) 通过减少炎症和内分泌网膜应激,保护脏免受缺血-反损伤 (IRI). ALDH2抑制了20-HETE合成,这是脏IRI进展的关键因素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 缺血-再输损伤 (IRI) 是一种常见的临床问题,其机制尚不清楚.
- 阿尔德脱酶2 (ALDH2) 是一种参与脂类阿尔德解毒的酶,可能会防止IRI.
研究的目的:
- 为了研究ALDH2在脏IRI病变发生中的作用.
- 阐明ALDH2发挥其保护作用的分子机制.
主要方法:
- 使用Aldh2敲除小鼠并将它们置于脏IRI.
- 进行蛋白质组分析以评估脂质代谢和炎症标志物.
- 研究了ALDH2,NCOR1和CYP4A转录之间的相互作用.
主要成果:
- Aldh2淘汰的小鼠在IRI后表现出恶化的功能障碍,亡和炎症.
- 缺少ALDH2导致促炎蛋白CYP4A及其代谢物20-HETE的水平增加.
- 发现ALDH2转移到核中,与NCOR1相互作用,并抑制Cyp4a转录,从而抑制20-HETE合成.
结论:
- ALDH2在减轻脏IRI方面发挥着关键的保护作用.
- ALDH2通过与NCOR1.1相互作用抑制Cyp4a转录来抑制20-HETE的产生.
- 向ALDH2-NCOR1-CYP4A通路可能为脏IRI提供治疗策略.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
484
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
484
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
472
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
472
Antihypertensive Drugs: Angiotensin II Receptor Blockers
579
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
579
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K


